Pharma Fridays – September 5, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves MiniMed 780g System for Adults with Type 2 Diabetes On September 2, Medtronic announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article